Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS
(2004; 134 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoGlossary
Ver el documento1. Introduction
Ver el documento2. Diagnostics
Ver el documento3. Access to quality HIV/AIDS medicines
Ver el documento4. Prices of medicines and diagnostics
Ver el documento5. List of manufacturers - medicines and diagnostics
Ver el documentoANNEX 1A. CD4+ T-cell enumeration technologies
Ver el documentoANNEX 1B. Summary of main characteristicsof Viral Load Technologies
Ver el documentoANNEX 2A. Registration status of products included in the sources and prices survey
Ver el documentoANNEX 2B. Sources of medicines
Ver el documentoANNEX 3. Further reading, references and contacts
Abrir esta carpeta y ver su contenidoANNEX 4. Untangling the web of price reductions: a pricing guide for the purchase of ARVs for developing countries.
 

4. Prices of medicines and diagnostics

4.1 Medicines

Table 1. Anti-infective medicines

 

Manufacturer

Indicative prices, US$

List prices, US$

 

No of manuf

No of countries

unit

max

min

median

25th perc

   

Anthelminthics

             

Brazil

Spain

albendazole

                 

chewable tablet, 400 mg

10

5

tab

0.180

0.015

0.036

0.022

0.048

1.317

Antibacterials, beta lactam medicines

                 

benzathine benzylpenicillin

                 

powder for injection, 1.44 g (=2.4 million IU) in 24-ml vial

1

1

vial

0.257

0.257

0.257

0.257

none

n/a

powder for injection, 1.44 g (=2.4 million IU) in 5-ml vial

3

3

vial

1.660

0.150

0.170

0.160

none

2.871

benzylpenicillin

                 

powder for injection, 3 g (=5 million IU)
(as sodium or potassium salt) in vial

3

3

vial

0.346

0.150

0.180

0.165

0.619

1.211

powder for injection, 600 mg
(=1 million IU) (as potasium salt) in vial

1

1

vial

0.268

0.268

0.268

0.268

none

n/a

cefixime

                 

paediatric oral suspension, 100 mg/5 ml

3

3

ml

0.201

0.025

0.034

0.030

none

1.856

paediatric oral suspension, 40 mg/5 ml

1

1

ml

0.108

0.108

0.108

0.108

none

n/a

powder for injection, 250 mg (as sodium salt)*

-

-

vial

       

none

n/a

tablet, 200 mg

3

2

tab

1.213

0.315

0.375

0.345

none

0.935

tablet, 400 mg

2

2

tab

0.560

0.165

0.363

0.264

none

1.713

ceftriaxone

                 

powder for injection, 1 g (as sodium salt) in vial

18

12

1g vial

12.680

0.600

1.086

0.852

0.687

8.247

powder for injection, 250 mg (as sodium salt) in vial

13

8

vial

2.809

0.230

0.775

0.650

none

2.684

powder for injection, 500 mg (as sodium salt) in vial

11

8

vial

8.140

0.320

0.825

0.756

none

4.322

procaine benzylpenicillin

                 

powder for injection, 3 g (=3 million IU) in vial

3

3

vial

0.237

0.144

0.170

0.157

none

n/a

Other antibacterials

azithromycin

                 

oral suspension, 200 mg/5 ml (dihydrate)

2

2

ml

0.200

0.040

0.120

0.080

0.078

0.310

capsule/tablet, 250 mg (dihydrate)

8

4

caps/tab

0.532

0.117

0.198

0.147

none

1.685

capsule/tablet, 500 mg (dihydrate)

8

5

caps/tab

1.500

0.250

0.470

0.308

0.447

4.120

capreomycin

                 

powder for injection, 1 g in vial

2

2

1g vial

5.000

5.000

5.000

5.000

none

2.730

chloramphenicol

                 

oily suspension for injection, 0.5 g/ml (as sodium succinate) in 2-ml ampoule

1

1

amp

0.620

0.620

0.620

0.620

none

n/a

oral suspension, 150 mg/5 ml (as palmitate)

1

1

ml

0.006

0.006

0.006

0.006

none

n/a

powder for injection, 1 g (sodium succinate) in vial

5

4

1g vial

0.680

0.175

0.231

0.200

0.371

1.055

ciprofloxacin

                 

tablet, 250 mg (as hydrochloride)

29

16

tab

0.605

0.011

0.041

0.018

0.048

0.227

tablet, 500 mg (as hydrochloride)

24

14

tab

1.186

0.022

0.054

0.027

0.058

0.421

clarithromycin

                 

oral suspension, 125 mg/5 ml*

-

-

ml

-

-

-

-

none

n/a

powder for injection, 500 mg

1

1

vial

0.700

0.700

0.700

0.700

none

23.346

tablet, 250 mg

15

10

tab

0.434

0.105

0.170

0.151

0.296

0.600

clindamycin

                 

capsule, 150 mg

2

2

caps

0.113

0.036

0.075

0.055

0.660

0.164

injection, 150 mg/ml (as phosphate) in 2-ml ampoule

1

1

amp

1.848

1.848

1.848

1.848

0.464

1.506

cycloserine

                 

capsule, 250 mg

2

2

caps

0.600

0.466

0.533

0.500

none

n/a

doxycycline

                 

capsule/tablet, 100 mg (hydrochloride)

15

10

caps/tab

0.114

0.007

0.015

0.011

0.052

0.112

erythromycin

                 

powder for injection, 500 mg (as lactobionate) in vial*

-

-

vial

-

-

-

-

none

n/a

powder for oral suspension, 125 mg (as stearate or ethylsuccinate)

10

9

ml

0.899

0.005

0.011

0.008

0.010

n/a

capsule/tablet, 250 mg (as stearate or ethylsuccinate)

19

10

caps/tab

0.068

0.020

0.031

0.026

none

0.099

capsule/tablet, 500 mg (as stearate or ethylsuccinate)

12

7

caps/tab

0.126

0.040

0.051

0.046

0.099

0.202

Other antibacteriald

gentamicin

                 

injection, 10 mg (as sulfate) in 2-ml vial

4

4

vial

0.295

0.045

0.073

0.045

0.072

n/a

injection, 40 mg (as sulfate) in 2-ml vial

7

4

vial

0.319

0.047

0.058

0.056

0.065

0.615

metronidazole

                 

injection, 500 mg in 100-ml vial

6

6

vial

2.880

0.300

1.268

0.827

0.189

3.039

Suppository, 1 g

1

1

sup

0.450

0.450

0.450

0.450

none

n/a

Suppository, 500 mg*

-

-

sup

       

none

n/a

ofloxacin

                 

IV infusion, 2 mg/ml (hydrochloride)

1

1

ml

0.032

0.032

0.032

0.032

none

17.828

tablet, 200 mg

14

7

tab

1.620

0.021

0.042

0.029

none

0.800

tablet, 400 mg

5

4

tab

0.661

0.062

0.100

0.082

1.014

n/a

rifabutin

                 

capsule, 150 mg

1

1

caps

0.753

0.753

0.753

0.753

none

2.813

silver nitrate

                 

solution (eye drops), 1%

1

1

ml

0.070

0.070

0.070

0.070

none

n/a

spectinomycin

                 

powder for injection, 2 g (as hydrochloride) in vial

3

3

vial

4.000

2.747

3.750

3.249

none

n/a

sulfadiazine

                 

injection, 250 mg (sodium salt) in 4-ml ampoule*

-

-

amp

-

-

-

-

none

n/a

tablet, 500 mg

4

4

tab

0.298

0.037

0.060

0.037

0.018

0.075

sulfamethoxazole+trimethoprim

                 

injection, 80+16 mg/ml in 5-ml ampoule*

-

-

amp

-

-

-

-

none

0.789

oral suspension, 200+40 mg/5 ml

15

9

ml

0.137

0.003

0.006

0.005

0.002

0.022

tablet, 100+20 mg

9

7

tab

0.187

0.004

0.006

0.005

none

0.026

tablet, 400+80 mg

23

13

tab

0.187

0.005

0.010

0.008

0.016

0.049

tablet, 800+160 mg

11

9

tab

0.100

0.009

0.019

0.015

0.069

0.129

tetracycline

                 

tablet, 500 mg

3

3

tab

0.021

0.014

0.014

0.014

0.031

n/a

Antifilarials

crotamiton

                 

cream/lotion 10%

1

1

ml

0.010

0.010

0.010

0.010

none

0.665

ivermectin

                 

scored tablet, 3 mg*

-

-

tab

-

-

-

-

none

n/a

scored tablet, 6 mg*

   

tab

       

none

n/a

lindane

                 

cream, lotion or powder 0.3%*

-

-

tube

-

-

-

-

none

n/a

permethrin

                 

cream, 5%*

-

-

tube

-

-

-

-

none

9.201

lotion, 1%

-

-

tube

-

-

-

-

none

n/a

Antifungal medicines

amphotericin B

                 

liposomal IV infusion, 5 mg/ml*

-

-

vial

-

-

-

-

none

172.950

liposomal IV infusion, powder for reconstitution 50 mg*

-

-

vial

-

-

-

-

none

76.089

powder for injection, 50 mg in vial

2

2

vial

9.000

5.181

7.091

6.136

2.426

2.567

clotrimazole

                 

cream, 1%

11

10

gram

0.240

0.007

0.027

0.018

0.653

1.622

pessary, 500 mg

2

2

pess

0.600

0.026

0.313

0.170

none

2.196

fluconazole

                 

capsule, 50 mg

4

2

caps

0.744

0.069

0.242

0.100

none

1.432

capsule, 150 mg

9

4

caps

1.840

0.034

0.500

0.280

0.151

4.303

capsule, 200 mg

9

5

caps

1.518

0.071

0.350

0.156

none

5.730

oral suspension, 50 mg/5 ml*

-

-

ml

-

-

-

-

none

n/a

solution for injection, 2 mg/ml in ampoule

5

2

ml

0.042

0.029

0.033

0.029

0.014

n/a

itraconazole

                 

capsule, 100 mg

3

3

caps

0.640

0.128

0.500

0.314

0.292

1.539

oral solution, 10 mg/ml*

-

-

ml

-

-

-

-

none

2.126

ketoconazole

                 

cream, 2%

7

5

gram

0.227

0.014

0.044

0.022

none

3.831

oral suspension, 100 mg/5 ml*

-

-

ml

-

-

-

-

none

0.087

tablet, 200 mg

16

10

tab

0.122

0.006

0.042

0.038

none

0.352

Antifungal medicines

miconazole

                 

cream/ointment 2% (as nitrate) 15 g tube

5

5

tube

1.176

0.350

0.418

0.400

none

n/a

cream/ointment 2% (as nitrate) 30 g tube

8

5

tube

0.980

0.130

0.435

0.394

0.618

2.395

nystatin

                 

lozenge, 100,000 IU*

-

-

loz

-

-

-

-

none

n/a

pessary, 100,000 IU

5

4

pess

0.030

0.017

0.024

0.021

none

0.071

tablet, 100,000 IU

2

2

tab

0.025

0.022

0.024

0.023

none

0.000

tablet, 500,000 IU

7

4

tab

0.069

0.022

0.036

0.030

none

0.081

Antiprotozoal medicines

pentamidine

                 

powder for injection, 200 mg (isetionate) in vial

1

1

vial

9.000

9.000

9.000

9.000

none

n/a

tablet, 200 mg*

-

-

tab

-

-

-

-

none

n/a

tablet, 300 mg*

-

-

tab

-

-

-

-

none

n/a

powder for injection, 300 mg (isetionate) in vial

4

4

vial

48.400

9.980

18.350

11.495

36.948

10.739

pyrimethamine

                 

tablet, 25 mg

2

2

tab

0.050

0.045

0.048

0.046

0.017

0.079

tinidazole

                 

tablet, 2 g*

-

-

tab

-

-

-

-

none

n/a

tablet, 500 mg

3

2

tab

0.015

0.010

0.012

0.011

none

0.549

Antiviral medicines

aciclovir

                 

cream, 5%

4

3

gram

0.986

0.037

0.450

0.039

0.409

1.424

powder for injection, 250 mg (as sodium salt) in 10-ml vial

3

3

vial

14.286

2.000

3.451

2.726

1.457

4.923

tablet, 200 mg

14

10

tab

0.540

0.030

0.054

0.039

0.086

0.699

tablet, 400 mg

12

8

tab

0.565

0.048

0.084

0.062

none

n/a

tablet, 800 mg

8

5

tab

1.020

0.098

0.259

0.155

none

2.115

cidofovir

                 

IV infusion, 75 mg/ml in vial*

-

-

vial

-

-

-

-

none

n/a

famciclovir

                 

tablet, 125 mg*

-

-

tab

-

-

-

-

none

3.095

tablet, 250 mg*

-

-

tab

-

-

-

-

none

5.524

foscarnet sodium

                 

IV infusion, 24 mg/ml

-

-

vial

-

-

-

-

none

40.326

ganciclovir

                 

capsule, 250 mg*

-

-

caps

-

-

-

-

none

4.027

capsule, 500 mg*

-

-

caps

-

-

-

-

none

n/a

powder for IV infusion, 500 mg in vial

1

1

vial

42.520

42.520

42.520

42.520

17.337

24.874

imiquimod

                 

cream, 5%*

-

-

tube

-

-

-

-

none

n/a

podofilox

                 

cream, 0.15%*

-

-

tube

-

-

-

-

none

17.182

solution or gel, 0.5%*

-

-

tube

-

-

-

-

none

11.040

podophyllum resin

                 

solution, 10-25%*

-

-

ml

-

-

-

-

none

n/a

valacyclovir

                 

tablet, 500 mg*

-

-

tab

-

-

-

-

none

2.300

valganciclovir

                 

tablet, 450 mg*

-

-

tab

-

-

-

-

none

28.090

Antiviral medicines - Antiretrovirals

abacavir (ABC)

                 

syrup, 20 mg/ml

1

1

ml

0.131

0.131

0.131

0.131

none

0.333

tablet, 300 mg

3

2

tab

1.983

1.215

1.404

1.310

none

3.828

didanosine (ddI)

                 

buffered chewable tablet, 100 mg

8

6

tab

0.376

0.179

0.298

0.241

0.317

1.370

buffered chewable tablet, 25 mg

5

5

tab

0.286

0.083

0.108

0.083

none

0.342

syrup, 2 g

2

2

ml

0.171

0.125

0.148

0.137

none

27.402

unbuffered enteric coated capsule, 125 mg*

-

-

caps

-

-

-

-

none

2.139

unbuffered enteric coated capsule, 250 mg

2

1

caps

0.666

0.648

0.657

0.653

none

3.923

unbuffered enteric coated capsule, 400 mg

2

1

caps

1.008

0.928

0.968

0.948

none

5.596

efavirenz (EFZ)

                 

capsule, 50 mg*

-

-

caps

-

-

-

-

none

n/a

capsule, 200 mg

4

2

caps

2.001

0.490

0.540

0.518

none

n/a

tablet, 600 mg

3

1

tab

1.582

1.300

1.467

1.384

2.182

n/a

indinavir (IDV)

                 

capsule, 200 mg

3

3

caps

0.600

0.166

0.312

0.239

none

0.966

capsule, 400 mg

6

3

caps

1.058

0.301

0.341

0.308

0.404

1.934

lamivudine (3TC)

                 

syrup, 50 mg/5 ml

3

3

ml

0.028

0.025

0.025

0.025

0.035

0.208

tablet, 150 mg

13

8

tab

1.531

0.086

0.150

0.124

0.237

3.129

tablet, 300 mg

1

1

tab

0.316

0.316

0.316

0.316

none

n/a

nelfinavir (NFV)

                 

capsule, 250 mg

6

4

caps

1.340

0.269

0.520

0.311

0.611

1.453

powder for suspension, 50 mg/g*

-

-

g

-

-

-

-

none

0.466

nevirapine (NVP)

                 

syrup, 50 mg/5 ml

3

2

ml

0.100

0.015

0.031

0.023

0.143

0.225

tablet, 200 mg

10

7

tab

1.984

0.133

0.257

0.173

none

4.426

saquinavir (SQV)

                 

capsule, 200 mg

2

1

caps

0.286

0.283

0.285

0.284

none

1.328

stavudine (d4T)

                 

capsule, 15 mg

2

2

caps

0.095

0.058

0.077

0.067

none

2.608

capsule, 20 mg

4

3

caps

0.101

0.051

0.082

0.065

none

2.705

capsule, 30 mg

11

7

caps

0.140

0.047

0.068

0.065

0.093

2.830

capsule, 40 mg

15

10

caps

2.101

0.058

0.101

0.079

0.182

2.925

syrup, 1 mg/ml

3

3

ml

0.050

0.011

0.048

0.049

none

0.596

tenofovir (TDF)

                 

tablet, 300 mg*

-

-

tab

-

-

-

-

none

12.797

zalcitabine (ddC)

                 

tablet, 0.375 mg

1

1

tab

0.402

0.402

0.402

0.402

none

n/a

tablet, 0.75 mg

2

2

tab

0.865

0.761

0.813

0.787

none

1.757

zidovudine (AZT or ZDV)

                 

capsule, 100 mg

14

10

caps

0.617

0.084

0.142

0.113

0.114

1.097

capsule, 250 mg

7

6

caps

1.450

0.307

0.450

0.346

none

2.051

tablet, 300 mg

9

6

tab

0.624

0.242

0.290

0.252

none

2.462

injection, 10 mg/ml in 20-ml vial

1

1

vial

5.000

5.000

5.000

5.000

1.443

8.532

oral solution, 50 mg/5 ml

3

3

ml

0.036

0.019

0.026

0.023

0.015

0.085

3TC/AZT

                 

tablet, 300/150 mg

11

7

tab

2.951

0.278

0.384

0.328

0.471

8.036

3TC/D4T/NVP

                 

tablet, 150/30/200 mg

1

1

tab

0.431

0.431

0.431

0.431

none

n/a

tablet, 150/40/200 mg

6

4

tab

0.496

0.275

0.402

0.346

none

n/a

ABC/3TC/ZDV

                 

tablet, 300/150/300 mg

2

2

tab

2.294

1.700

1.997

1.849

none

13.566

AZT/3TC/NVP

                 

tablet, 300/150/200 mg

2

1

tab

0.499

0.463

0.481

0.472

none

n/a

lopinavir/ritonavir (LPV/r)

                 

oral solution, 20+80 mg/ml*

-

-

ml

-

-

-

-

none

8.060

capsule, 133.3+33.3 mg*

-

-

caps

-

-

-

-

none

2.687

 

* No price information

none - no purchase has been made for this product, therefore no minimum price payable is available

n/a - not available


Table 2. Antineoplastic medicines

 

Manufacturer

Indicative prices, US$

List prices, US$

Cytotoxic medicines

No of manuf

No of countries

unit

max

min

median

25th perc

Brazil

Spain

bleomycin

                 

powder for injection, 15 mg (as sulfate) in vial

2

2

vial

21.000

18.000

19.500

18.750

22.515

13.930

calcium folinate (leucovorin)

                 

tablet, 15 mg

3

3

tab

3.496

0.012

2.561

1.287

none

0.767

doxorubicine HCl

                 

powder for injection, 10 mg in 5-ml vial

4

4

vial

23.720

3.000

7.660

5.063

3.196

7.286

powder for injection, 50 mg in 25-ml vial

4

4

vial

111.111

14.000

29.525

17.675

14.739

31.858

etoposide

                 

capsule, 100 mg*

 

- caps

         

none

11.566

injection, 20 mg/ml in 5-ml ampoule

5

3

amp

31.211

1.723

9.850

5.000

2.921

2.492

methotrexate

                 

injection, 25 mg/ml (as sodium salt) in 2-ml vial

2

2

vial

18.100

1.400

9.750

5.575

2.062

3.603

powder for injection, 50 mg (as sodium salt) in 2-ml vial

3

3

vial

4.310

2.000

3.360

2.680

none

3.772

tablet, 2.5 mg

4

3

tab

0.188

0.031

0.068

0.057

none

0.056

vinblastine

                 

powder for injection, 10 mg (sulfate) in 10-ml vial

3

2

vial

14.260

1.400

2.347

1.874

11.684

6.815

vincristine

                 

injection, 1 mg/ml (sulfate) in vial

3

3

vial

4.500

0.674

3.080

1.877

2.405

n/a

powder for injection, 1 mg (sulfate) in 1-ml vial

1

1

vial

2.000

2.000

2.000

2.000

2.405

5.468

vinorelbine

                 

injection concentrate 10 mg/ml in vial

1

1

ml

16.480

16.480

16.480

16.480

143.086

21.352

Table 3. Medicines used for the treatment of mental and substance use disorders

 

Manufacturer

Indicative prices, US$

List prices, US$

Medicines used in depressive disorders

No of manuf

No of countries

unit

max

min

median

25th perc

Brazil

Spain

amitriptyline

                 

tablet, 25 mg (as hydrochloride)

9

5

tab

0.065

0.004

0.008

0.007

0.010

0.03

fluoxetine

                 

tablet, 20 mg

10

7

tab

0.491

0.015

0.078

0.040

0.034

0.221

Medicines used in generalized anxiety and sleep disorders

                 

lorazepam

                 

injection, 4 mg/ml in ampoule*

-

-

amp

-

-

-

-

none

n/a

tablet, 1 mg*

-

-

tab

-

-

-

-

none

0.027

methotrimepazine/levomepromazine

                 

injection, 25 mg/ml in ampoule

-

-

amp

-

-

-

-

none

0.181

tablet, 25 mg

2

2

tab

0.108

0.033

0.071

0.052

0.038

0.059

Medicines used in the treatment of opioid dependence

buprenorphine

                 

sublingual tablet, 200 mcg (hydrochloride)*

-

-

tab

-

-

-

-

none

0.370

sublingual tablet, 400 mcg (hydrochloride)*

-

-

tab

-

-

-

-

none

n/a

naltrexone HCl

                 

tablet, 50 mg

2

2

tab

1.277

0.875

1.076

0.976

none

2.444

Opioid analgesics

codeine

                 

tablet, 30 mg (phosphate)

5

5

tab

0.066

0.020

0.034

0.030

0.232

0.100

methadone

                 

tablet, 5 mg

1

1

tab

0.185

0.185

0.185

0.185

none

0.055

morphine

                 

injection, 10 mg/ml (sulfate or HCl), in 1-ml ampoule

6

4

amp

1.998

0.271

0.470

0.311

0.495

0.231

oral solution, 10 mg/5 ml (sulfate or HCl)

4

2

ml

1.000

0.055

0.058

0.056

none

n/a

tablet, modified release, 10 mg (sulfate)

   

tab

       

none

0.137

pethidine

                 

injection, 50 mg/ml (hydrochloride) in 1-ml ampoule

4

3

amp

0.450

0.284

0.370

0.334

0.344

n/a

injection, 50 mg/ml (hydrochloride) in 2-ml ampoule

7

6

amp

1.773

0.258

0.505

0.392

none

0.598

tablet, 50 mg

2

1

tab

0.130

0.125

0.128

0.129

none

n/a

tablet, 100 mg

1

1

tab

0.150

0.150

0.150

0.150

none

n/a

 

* No price information

none - no purchase has been made for this product, therefore no minimum price payable is available

n/a - not available


Table 4. Analgesics

 

Manufacturer

Indicative prices, US$

List prices, US$

Opioid analgesics

No of manuf

No of countries

unit

max

min

median

25th perc

Brazil

Spain

codeine

                 

tablet, 30 mg (phosphate)

5

5

tab

0.066

0.020

0.034

0.030

0.232

0.100

methadone

                 

tablet, 5 mg

1

1

tab

0.185

0.185

0.185

0.185

none

0.055

morphine

                 

injection, 10 mg/ml (sulfate or HCl), in 1-ml ampoule

6

4

amp

1.998

0.271

0.470

0.311

0.495

0.231

oral solution, 10 mg/5 ml (sulfate or HCl)

4

2

ml

1.000

0.055

0.058

0.056

none

n/a

tablet, modified release, 10 mg (sulfate)

   

tab

       

none

0.137

pethidine

                 

injection, 50 mg/ml (hydrochloride) in 1-ml ampoule

4

3

amp

0.450

0.284

0.370

0.334

0.344

n/a

injection, 50 mg/ml (hydrochloride) in 2-ml ampoule

7

6

amp

1.773

0.258

0.505

0.392

none

0.598

tablet, 50 mg

2

1

tab

0.130

0.125

0.128

0.129

none

n/a

tablet, 100 mg

1

1

tab

0.150

0.150

0.150

0.150

none

n/a

Table 5. Gastrointestinal medicines

 

Manufacturer

Indicative prices, US$

List prices, US$

Antacids and other antiulcer medicines

No of manuf

No of countries

unit

max

min

median

25th perc

Brazil

Spain

omeprazole

                 

capsule, 10 mg

8

6

caps

0.312

0.014

0.070

0.050

0.028

n/a

capsule, 20 mg

19

9

caps

1.046

0.011

0.093

0.030

0.034

0.210

capsule, 40 mg

10

6

caps

1.207

0.030

0.177

0.088

none

0.905

powder for injection, 40 mg (as sodium salt) in vial

1

1

vial

3.000

3.000

3.000

3.000

1.371

9.584

powder for IV infusion, 40 mg (as sodium salt) in vial

2

2

vial

3.000

1.950

2.475

2.213

none

n/a

Antiemetic medicines

dimenhydrinate

                 

tablet, 50 mg

4

4

tab

0.056

0.005

0.025

0.010

none

0.129

metoclopramide

                 

injection 5 mg/ml in 2-ml ampoule

5

5

amp

0.219

0.055

0.112

0.108

0.062

0.177

tablet, 10 mg (as hydrochloride)

9

7

tab

0.027

0.002

0.007

0.006

0.005

0.050

prochlorperazine

                 

injection, 12.5 mg/ml

2

2

ml

0.359

0.130

0.245

0.187

none

n/a

tablet, 5 mg

3

3

tab

0.009

0.004

0.008

0.006

none

n/a

Laxatives

                 

docusate sodium

                 

capsule, 100 mg*

-

-

tab

-

-

-

-

none

n/a

 

* No price information

none - no purchase has been made for this product, therefore no minimum price payable is available

n/a - not available


4.2 UN Bulk Procurement Scheme 2004: Specifications of HIV test kits - Simple/Rapid,Elisa and Supplemental Assays

SIMPLE/RAPID ASSAYS

Assay name
(Manufacturer)

Company’s Order Code

No. of tests per kit

Guaranteed Shelf-life/Storage temp (°C)

HIV type1

Assay type Antigen

Sample type

Equipment requirements2

Cost/test3
€/¥

Cost/test3
US $

BIOLINE HIV 1/2 3.0
(Standard Diagnostics Inc.)

03FK10

30

16 months/
2°-30°

HIV1
HIV 2

lateral flow
recombinant proteins

whole blood
serum/plasma

D, G

 

0.47

BIONOR HIV-1 & 2
(Bionor AS)

DN061

250

10 months/
2°-8°

HIV 1+2

synthetic peptides

whole blood
serum/plasma

E, G, Special Equipment

 

1.00

CAPILLUS HIV-1/HIV-2
(Trinity Biotech)

6048G

100

9 months/
2°-8°

HIV 1+2

agglutination
recombinant proteins

whole blood
serum/plasma

G

€ 1.00

 

DETERMINETM HIV-1/2
Abbott Diagnostics)

7D23-13

100

6 -9 months/
2°-30°

HIV 1+2

lateral flow
recombinant protein,
synthetic peptide

whole blood
serum/plasma

D, G

 

Access countries:
0.80
Elsewhere: 1.00

DIAGNOSTIC KIT for HIV
(1+2) ANTIBODY
(COLLOIDAL GOLD)
(Shanghai Kehua)
(SEAR & WR only)

KH-R-02

50

15 months/
4°-30°

HIV 1+2

lateral flow

whole blood
serum/plasma

D, G

 

0.60

FIRST RESPONSETM HIV
1-2-0 Card Test
(Premier Medical Corp)

105FRC30

30

15 months/
2°-30°

HIV 1+2

lateral flow
recombinant proteins

whole blood
serum/plasma

D, G

 

0.67

GENEDIA HIV 1/2 Rapid
3.0 (Green Cross)
(SEAR & WPR only)

F3302

30

18 months/
2°-30°

HIV 1+ 2

lateral flow
recombinant proteins

whole blood
serum/plasma

D, G

 

0.70

GENIE II HIV-1/HIV-2
(Bio-Rad Laboratories)

72323

40

12 months/
2°-8°

HIV 1 + 2

lateral flow
recombinant proteins
synthetic peptides

serum/plasma

D, G

€ 2.00

 

HIV 1&2 DOUBLECHECK
(Orgenics Ltd)

60332000

40

15 months/
4°-8°

HIV 1+2

lateral flow
recombinant proteins
synthetic peptides

serum/plasma

G

 

1.20

HIV TRIDOT
(J Mitra & Co., India)

IR130010

10

10 months/
4°-8°

HIV 1

flow through

serum/plasma

G

€ 1.10

 
 

IR130050

50

 

HIV 2

recombinant proteins

   

€ 1.00

 
 

IR130100

100

         

€ 0.90

 
 

IR130200

200

         

€ 0.80

 

IMMUNOCOMB II BISPOT
HIV1 & 2
(Orgenics Ltd)

60432002

36

15 months/
4°-8°

HIV 1
HIV 2

dipstick
synthetic peptides

serum/plasma

D, G

 

1.30

INSTANTCHEKTM HIV
1+2 RAPID TEST
(EY Laboratories)

8-1003-40

40

9 months/
15°-28°

HIV 1+2

lateral flow

whole blood

G

 

1.09

 

8-1003-100

100

     

serum/plasma

   

0.95

SERODIA HIV-1/2
(Fujirebio)

220658

100

12 months/
2°-10°

HIV 1+2

agglutination

serum/plasma

C, D, G

¥130

(1.19)

 

226063

220

   

recombinant proteins

   

¥130

(1.19)

UNI-GOLDTM HIV-1/HIV-2
(Trinity Biotech)

1206502

20

9 months/
2°-27°

HIV 1+2

lateral flow
recombinant proteins

whole blood
serum/plasma

G

€ 1.15

 

Notes:

1 Assays denoted as HIV 1 HIV 2 are able to discriminate between HIV-1 and HIV-2, those denoted as HIV 1+2 are not capable to discrimination

2 Equipment requirements: A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G:For small volume testing 1 to 40 samples daily, Special Equipment: Bionortesting station required approximate cost US $950

3 Please note that this price does not include freight nor other charges


ELISA ASSAYS

Assay name
(Manufacturer)

Company’s Order Code

No. of tests per kit

Guaranteed Shelf-life/Storage temp (°C)

HIV type1

Assay type Antigen

Sample type

Equipment requirements2

Cost/test3
€/¥

Cost/test3
US $

ANTI-HIV 1 + 2
ANTIBODIES ELISA
DIAGNOSTICS KIT
(Shanghai Kehua)
(SEARO & WPRO only)

KH-T-10

96

5 months/
2°-8°

HIV 1+2

recombinant proteins
synthetic peptides

4520/620nm

A, B, C, D, E, F

 

0.27

ENZYGNOST ANTI-HIV
1/2 PLUS
(Dade Behring AG)
Enzygnost/TMB reagent kit

OQFK135

2 x 96

12 months/
2°-8°

HIV 1+2
O

recombinant proteins

450/650 nm

A, B, C, D, E, F

 

0.99

 

OQFK215

10 x 96

           

0.75

 

OUVP175

960

           

Gratis

GENEDIA HIV Ag-Ab
(Green Cross)
(SEARO & WPRO only)

D1305

480

12 months/
2°-8°

HIV 1+ 2
O
HIV Ag

recombinant proteins
synthetic peptides

450/620nm

A, B, C, D, E, F

 

0.40

GENSCREEN HIV Ag-Ab
(Bio-Rad Laboratories)

72375

96

12 months/
2°-8°

HIV 1+2
O
HIV Ag

recombinant proteins
synthetic peptides

450/620 nm

A, B, C, D, E, F

€ 0.55

 
 

72376

480

         

€ 0.50

 

HIV EIA
(AniLabsystems Ltd Oy)

6111011

96

12 months/
4°-8°

HIV 1+2

synthetic peptides

450 nm

A, B, C, D, E, F

€ 0.40

 
 

6111012

480

         

€ 0.36

 
 

6111013

960

         

€ 0.34

 

MUREX HIV Ag-Ab
(Abbott Diagnostics)

L/N7G79-01

96

6 months/
2°-8°

HIV 1+ 2
O
HIV Ag

recombinant proteins synthetic peptides

450/620 - 650nm

A, B, C, D, E, F

 

1.20

 

L/N7G79-02

480

           

0.80

UBI HIV-1/2 EIA
(United Biomedical)

680328

192

14 months/
2°-8°

HIV 1+2

synthetic peptides

492/620 nm

A, B, C, D, E, F

 

0.40

VIRONOSTIKA HIV UNIFORM II PLUS O
(bioMérieux BV)

284017

192

12 months/
2°-8°

HIV 1+2
O

recombinant proteins
synthetic peptides

450/620 nm

A, B, C, D, E, F

€ 0.64

 
 

284018

576

         

€ 0.46

 

Notes:

1 Assays denoted as HIV 1 HIV 2 are able to discriminate between HIV-1 and HIV-2, those denoted as HIV 1+2 are not capable to discrimination

2 Equipment requirements: A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G:For small volume testing 1 to 40 samples daily, Special Equipment: Bionortesting station required approximate cost US $950

3 Please note that this price does not include freight nor other charges


SUPPLEMENTAL ASSAYS

Confirmatory assays

Assay name
(Manufacturer)

Company’s Order Code

No. of tests per kit

Guaranteed Shelf-life/Storage temp (°C)

HIV type1

Assay type Antigen

Sample type

Equipment requirements2

Cost/test3
€/¥

Cost/test3
US $

HIV BLOT 2.2
(Genelabs Diagnostics)

11031–036

36

15 months/
2°–8°

HIV 1
HIV 2

viral lysate + synthetic peptide

NA

C, D, E

 

10.97

INNO-LIATMHIV I/II SCORE
(Innogenetics)

80540

20

2°–8°

HIV 1
HIV 2

recombinant proteins
synthetic peptides

NA

D, E

€ 15.50

 

PEPTI-LAV 1–2
(Bio-Rad Laboratories)

72253

10

12 months/
2°–8°

HIV 1
HIV 2

synthetic peptides

NA

C, D, E

€ 15.00

 

NEW LAV BLOT I
(Bio-Rad Laboratories)

72252

18

12 months/
2°–8°

HIV 1

viral lysate

NA

D, E

€ 13.00

 

NEW LAV BLOT II
(Bio-Rad Laboratories)

72252

18

12 months/
2°–8°

HIV 2

viral lysate

NA

D, E

€ 13.00

 

Notes:

1 Assays denoted as HIV 1 HIV 2 are able to discriminate between HIV-1 and HIV-2, those denoted as HIV 1+2 are not capable to discrimination

2 Equipment requirements: A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G:For small volume testing 1 to 40 samples daily, Special Equipment: Bionortesting station required approximate cost US $950

3 Please note that this price does not include freight nor other charges

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013